construction release_alert

Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.

cancel

A Phase I open label dose escalation safety and tolerability study of INCB054828 in subjects with advanced malignancies

Clinical Trial Grant

Duke Scholars

Principal Investigator Niharika Bansal Mettu Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Incyte Corporation

Start Date

September 1, 2015

End Date

August 31, 2024

Administered By

Duke Cancer Institute

Awarded By

Incyte Corporation

Start Date

September 1, 2015

End Date

August 31, 2024